Immunophenotyping at the Time of Diagnosis Distinguishes Two Groups of Nasopharyngeal Carcinoma Patients: Implications for Adoptive Immunotherapy
<p><b>Background:</b> Adoptive immunotherapy with EBV-specific CTLs (EBV-CTL) has been used to treat EBV-associated nasopharyngeal carcinoma (NPC) but only a fraction of the patients shows noticeable clinical response.</p><p><b>Patients and Methods: </b>Sixt...
Main Author: | Jiang Li, Qiu-yan Chen, Haoyuan Mo, Yi-lan Zhang, Zhou-feng Huang, Yi-xin Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2011-01-01
|
Series: | International Journal of Biological Sciences |
Online Access: | http://www.biolsci.org/v07p0607.htm |
Similar Items
-
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
by: Jiang Li, et al.
Published: (2007-11-01) -
Research Progress of Immunotherapy in Nasopharyngeal Carcinoma
by: Jian-nan SHAO
Published: (2017-09-01) -
Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response
by: Corey Smith, et al.
Published: (2017-02-01) -
Quantitative study of cytotoxic T-lymphocyte immunotherapy for nasopharyngeal carcinoma
by: Shengjun Wang, et al.
Published: (2012-03-01) -
Radiomic Immunophenotyping of GSEA-Assessed Immunophenotypes of Glioblastoma and Its Implications for Prognosis: A Feasibility Study
by: Justin Bo-Kai Hsu, et al.
Published: (2020-10-01)